Wesley C. Minto

Induction of ER Stress by an AAV5 BDD FVIII Construct Is Dependent on the Strength of the Hepatic-Specific Promoter

Guoying Yu, J. Vowinckel, S. Bunting, 2020, Molecular therapy. Methods & clinical development.

Clearance of Heparan Sulfate and Attenuation of CNS Pathology by Intracerebroventricular BMN 250 in Sanfilippo Type B Mice

P. Fitzpatrick, S. Bunting, Catherine Vitelli, 2017, Molecular therapy. Methods & clinical development.

IL‐31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH

K. Kowdley, M. Trauner, M. Noureddin, 2022, Hepatology.

Histologic characterization of the progression of central nervous system pathology in the mucopolysaccharidosis IIIB (MPS IIIB, Sanfilippo syndrome type B) mouse model and bio-distribution and efficacy of the intracerebroventricular enzyme replacement therapy, BMN 250

P. Fitzpatrick, S. Bunting, A. Bagri, 2016 .

Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the Mdr2-/- mouse model of sclerosing cholangitis

H. Scharnagl, M. Trauner, T. Stojaković, 2023, JHEP reports : innovation in hepatology.

Prophylactic Prednisolone Promotes AAV5 Hepatocyte Transduction Through the Novel Mechanism of AAV5 Coreceptor Platelet-Derived Growth Factor Receptor Alpha Upregulation and Innate Immune Suppression

Britta Handyside, Choong-Ryoul Sihn, Linley Mangini, 2023, Human gene therapy.